Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Silvers

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Molecular Cancer Therapeutics|September 10, 2015
Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA ExpressionBeverly A Teicher, Eric Polley, Mark Kunkel, et al.
Clinical Epigenetics|June 27, 2020
Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targetsJulia Krushkal, Thomas Silvers, William C Reinhold, et al.
Cancer Research Communications|September 17, 2025
RAS Pathway Inhibitors Combined with Targeted Agents Are Active in Patient-Derived Spheroids with Oncogenic KRAS Variants from Multiple Cancer TypesZahra Davoudi, Thomas S Dexheimer, Nathan P Coussens, et al.
Cancer Chemotherapy and Pharmacology|May 19, 2019
Exposure time versus cytotoxicity for anticancer agentsDavid M Evans, Jianwen Fang, Thomas Silvers, et al.
Analytical Biochemistry|April 21, 2005
A high-throughput fluorescence-anisotropy screen that identifies small molecule inhibitors of the DNA binding of B-ZIP transcription factorsVikas Rishi, Timothy Potter, Julie Laudeman, et al.
Journal of the National Cancer Institute|June 2, 2016
Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA ExpressionEric Polley, Mark Kunkel, David Evans, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Molecular Cancer Therapeutics|September 10, 2015
Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA ExpressionBeverly A Teicher, Eric Polley, Mark Kunkel, et al.
Clinical Epigenetics|June 27, 2020
Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targetsJulia Krushkal, Thomas Silvers, William C Reinhold, et al.
Cancer Research Communications|September 17, 2025
RAS Pathway Inhibitors Combined with Targeted Agents Are Active in Patient-Derived Spheroids with Oncogenic KRAS Variants from Multiple Cancer TypesZahra Davoudi, Thomas S Dexheimer, Nathan P Coussens, et al.
Cancer Chemotherapy and Pharmacology|May 19, 2019
Exposure time versus cytotoxicity for anticancer agentsDavid M Evans, Jianwen Fang, Thomas Silvers, et al.
Analytical Biochemistry|April 21, 2005
A high-throughput fluorescence-anisotropy screen that identifies small molecule inhibitors of the DNA binding of B-ZIP transcription factorsVikas Rishi, Timothy Potter, Julie Laudeman, et al.
Journal of the National Cancer Institute|June 2, 2016
Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA ExpressionEric Polley, Mark Kunkel, David Evans, et al.
Pageof 2